Back
Beta Bionics 10K Form
Sell
29
BBNX
Beta Bionics
Last Price:
$14.74
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBNX News And Ratings
See the #1 stock for the next 7 days that we like better than BBNX
BBNX Financial Statistics
Sales & Book Value
Annual Sales: | $12M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $0.00 |
Price / Book: | 0 |
Profitability
Net Income (TTM): | $0 |
---|---|
Gross Margin: | $6.3M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Beta Bionics Earnings Forecast
Key Beta Bionics Financial Ratios
-
The Gross Profit Margin over the past 2 years for BBNX is 52.59%.
-
The Selling, General & Administrative Expenses for BBNX have been equal to 201.88% of Gross Profit Margin.
-
The Research & Development expenses have been 149.59% of Revenue.
-
The Net Earning history of BBNX is -367.64% of Total Revenues.
-
Per Share Earnings over the last 2 years have been positive in 1 years.
Beta Bionics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Current Symbol: | BBNX |
Website: | betabionics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
BBNX Technical Analysis vs Fundamental Analysis
Sell
29
Beta Bionics (BBNX)
is a Sell
Is Beta Bionics a Buy or a Sell?
-
Beta Bionics stock is rated a SellThe current Beta Bionics [BBNX] share price is $14.68. The Score for BBNX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.